Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3-4
|
| pubmed:dateCreated |
1979-11-28
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0001-7078
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
69
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
237-46
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:39431-Anoxia,
pubmed-meshheading:39431-Central Nervous System Stimulants,
pubmed-meshheading:39431-Female,
pubmed-meshheading:39431-Humans,
pubmed-meshheading:39431-Hypercapnia,
pubmed-meshheading:39431-Male,
pubmed-meshheading:39431-Piperazines,
pubmed-meshheading:39431-Respiration,
pubmed-meshheading:39431-Triazines
|
| pubmed:articleTitle |
Functional evaluation of a new analeptic drug (vectarion) in patients with chronic hypoxemia and hypercapnia (preliminary study).
|
| pubmed:publicationType |
Journal Article
|